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Abstract 
Human immunodeficiency Virus (HIV) infection and Acquired immunodeficiency syndrome (AIDS) have become global health concern. 
The uses of antiretroviral therapy (ART) have been shown to improve health but are associated with a wide array of immunologic, 
endocrinologic and metabolic abnormalities. This study determined the levels of fertility hormones, CD4 and CD8+Tcells in HIV 
seropositive subjects and seronegative subjects. A total of one hundred and seventy HIV seropositive subjects were investigated while fifty 
HIV seronegative subjects served as controls. Eighty-five HIV seropositive subjects were on antiretroviral therapy consisting of three drug 
combinations (Zidovudine 300mg twice daily; Lamivudine 150mg twice daily; Tenofovir 300mg once daily; Efavirenz 600mg once daily 
and Stavudine 30mg twice daily for body weight of <60kg or 40mg twice daily for body weight of >60kg). Eighty five HIV seropositive 
subjects were not on antiretroviral therapy. Fertility hormones (Follicle Stimulating Hormone, Leutinising Hormone, Prolactin and 
Testosterone) were determined using Enzyme linked immunosorbent assay (ELISA) method. CD4+Tcells and CD8+Tcells were determined 
using flow cytometry. The serum levels of the fertility hormones in HIV seropositive males on antiretroviral therapy (ART) and those not  
on ART showed significant reduction (P<0.05) when compared with that of HIV seronegative male control subjects. The serum levels of the 
hormones in HIV seropositive females on ART and those not on ART showed no significant difference compared with those of HIV 
seronegative control female subjects. The CD4+T cell counts of HIV seropositive male and female subjects on ART and those not on ART 
showed significant reduction (P<0.05) when compared with the HIV seronegative control subjects. There was significant increase in the 
levels of CD8+T cell counts of the HIV seropositive males and females on ART.  HIV infection is associated with variations in the male 
hormonal fertility profiles but without significant effect on women hormonal fertility profiles. However, CD4+Tcells decrease while CD8+T 
cells increase as HIV/AIDS progresses. 
 





Human immunodeficiency Virus (HIV) infection and AIDS 
have become global health issues of great concern. More than 
33 million people around the world are infected with HIV 
with nearly 5500 dying daily from HIV and AIDS related 
complications (Myer, 2010). According to Idoko (2013), the 
current HIV statistic in Nigeria shows that 3.4 million 
Nigerians are living with HIV and 58.0 % among these are 
women. It has been reported that infection by HIV/AIDS and 
its antiretroviral therapy are associated with a wide array of 
endocrine and metabolic abnormalities which include adrenal 
insufficiency, thyroid, hypogonadism and hypopituitarism 
(Dobs et al,1988; Dobs et al,1996; Poretsky et al, 1995). 
Although, treatment with antiretroviral drugs increase the life 
expectancy of people infected with HIV, the virus affects the 
body’s ability to produce and maintain hormone levels. 
Conde et al,(2009) reported that some drugs that are used to 
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treat HIV related conditions also affect hormone levels. It has 
also been shown that the HIV infection is associated with 
altered fertility hormone levels while the antiretroviral 
therapy may have no effect on the fertility hormones 
(Ogundahunsi et al,2011). HIV/AIDS also have effects on the 
immune system. In fact, hypogonadism especially lower 
testosterone levels have been correlated with weight loss and 
lower CD4 cell counts (Highleyman, 2010). HIV infects 
primarily vital cells in the human immune system such as 
helper T cells (CD4+Tcells), macrophages and dendritics 
cells (Cunnigham et al., 2010). After initial infection of the 
human host, the pace of immunodeficiency development, 
susceptibility to infection and malignancies become manifest 
and are generally associated with the rate of CD4+ declines 
(Mandy, 2009).  The rate of CD4+ decline varies 
considerably from person to person and is not constant 
throughout the stages of HIV infection. CD4 T-cells is the 
primary but not the only leukocyte that may be infected with 
HIV (Mandy, 2009). The absolute CD4+Tcell counts 
provides a powerful laboratory measurement of predicting, 
staging and monitoring disease progression and response to 
treatment in HIV- infected individuals (Turner et al.,1994; 
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Oluboyo et al, 2006) but there are some CD8+Tcells that 
suppress or regulate the ongoing immune responses 
(Davenport and Petravic, 2010). These subsets of 
CD8+Tcells (cytotoxic T-lymphocytes) have the capacity of 
mediating the lysis of infected autologous cells (Cunningham 
et al, 2010). 
 Thus, the study set to determine the fertility hormones, 
CD4+T cells and CD8+T cells in HIV seropositive subjects 
to see if there are variations in the hormonal fertility profiles 
in Onitsha, Nigeria. 
 
MATERIALS AND METHODS 
 
The study subjects comprised 170 HIV seropositive adults 
attending a voluntary counseling and testing (VCT) clinic at 
Onitsha, Anambra State, Nigeria and 50 seronegative 
subjects served as control. Eighty-five (85) HIV seropositive 
subjects were on antiretroviral therapy consisting of three 
drug combinations (Zidovudine 300mg twice daily; 
Lamivudine 150mg twice daily; Tenofovir 300mg once 
daily; Efavirenz 600mg once daily and Stavudine 30mg twice 
daily for body weight of <60kg or 40mg twice daily for body 
weight of >60kg) while the remaining eighty five (85) 
subjects were not on ART. Adequate precautions for 
collection and handling of blood specimen were observed 
throughout the research work. The blood specimens for 
CD4+Tcells and CD8+Tcells were collected into 
Ethylenediaminetetraaceticacid (EDTA) anticoagulated 
bottles and were analyzed immediately. The CD4+ and 
CD8+Tcell counts were determined using Partec cyflow 
counter (Partec GMBH, Germany).   The blood specimens 
for the fertility hormones were collected into plain specimen 
containers without anticoagulant. The samples for hormonal 
assay were allowed to clot and retracted before centrifugation 
at 1200 rpm for 5minutes using a bench centrifuge. The 
serum was collected and preserved in a freezer at -20
o
C until 
analysis. The hormones were determined using Enzyme 
immunoassay kits (Diagnostic Automation) and the 
concentrations of the hormones were determined using 
Enzyme linked immunoassay (ELISA) reader (STAT Fax – 
2100 machine from Awareness Technology, Germany). 
 
Statistical analysis of data 
The mean and the standard deviations of the data were 
obtained using Windows software package for Social 
Sciences (SPSS) version16. T-test and Analysis of Variance 
(ANOVA) were used to compare the mean and the standard 






The mean levels of fertility hormones, CD4 + T cells and 
CD8 +T cells in HIV seropositive subjects and controls are 
shown in table 1. There were significant decreases in the 
mean levels of Follicle stimulating hormones (FSH), 
Leutinising hormone (LH), Prolactin, Testosterone and CD4+ 
T cells of HIV subjects when compared with the controls. 
However, there was a significant increase in the mean CD8 
+T cells in HIV seropositive subjects compared with the 
controls. Table 2 shows the mean levels of fertility 
hormones, CD4 + T cells and CD8 +T cells in HIV 
seropositive male subjects and male controls. Furthermore, 
there were significant decreases in the mean levels of Follicle 
stimulating hormones (FSH), Leutinising hormone (LH), 
Prolactin, Testosterone and CD4+ T cells of the HIV 




Table 1 :  
Fertility hormones, CD4 + T cells and CD8 +T cells in HIV Subjects on drug therapy, those not on drug therapy and Control subjects 
Parameters HIV Subjects on ART 
N= 85 







FSH (mIU/ml) 5.40±2.18    5.84± 2.12 6.88±1.45 8.25   0.00* 
LH  (mIu/ml) 8.68±4.63    8.39±3.55 9.73±2.85 7.20 0.02* 
Prolactin (ng/ml) 6.23±2.30    6.53±2.26 7.63±1.99 7.58 0.00* 
Testosterone (ng/ml) 2.29±1.70 2.72±0.95 6.17±0.46 8.43 0.00* 
CD4 +Tcells (cells /l) 397.95±186.52 442.96±1223.00 878.86±195.81 79.64 0.00* 
CD8 +Tcells (cells /l) 872.02±242.11 872.76±216.19 440.30±111.17 35.98 0.00* 
*Statistically significant at P<0.05 
 
 
Table 2 :   
Fertility Hormones, CD4 + T cells and CD8 +T cells of HIV seropositive and seronegative male subjects.  
Parameters HIV Male Subjects on ART 
 N= 40 
HIV Male Subjects 
Not on ART  N= 40 
Control Males  
N= 25 
F-value p-value 
FSH (mIU/ml) 5.33±2.25       3.41± 2.01  7.30±1.47  8.868 0.00* 
LH  (mIu/ml) 6.70±4.35    7.08±3.18 9.95±2.27 7.359 0.00* 
Prolactin (ng/ml) 5.45±2.26    6.15±2.26 7.68±2.22  7.672 0.00* 
TESTOSTERONE(ng/ml) 4.28±1.70    5.00±1.72 6.17±1.67 9.433 0.00* 
CD4 +Tcells (cells /l) 337.48±127.22 402.55±181.12 937.60±189.67 97.952 0.00* 
CD8 +Tcells (cells /l) 872.02±242.11 916.25±203.37 447.30±120.98 37.540 0.00* 
*Statistically significant at P<0.05 
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Table 3 :   
Fertility Hormones, CD4 + T cells and CD8 +T cells of HIV seropositive subjects and seronegative female subjects.  
Parameters HIV Female Subjects on ART 
 N= 45 






FSH (mIU/ml) 5.46 ± 2.12                  6.21 ±2.23 6.468±1.42 2.458 0.09 
LH  (mIu/ml) 10.44±4.90 9.69±3.93 9.53±3.43 0.110    0.60  
PROLACTIN (ng/ml) 6.93 ± 2.42                            6.90 ±2.64 7.57±1.76 0.165 0.48 
Testosterone(ng/m) 0.52±0.27              0.43± 0.19 0.46±1.66 0.695 0.490 
CD4 +Tcells (cells /l) 451.71±245.81 478.87±264.88 820.12±201. 94 61.32 0.00* 
CD8 +Tcells (cells /l) 872.02±242.11 834.11±229.00 433.10+101.37 34.41 0.00* 
*Statistically significant at P<0.05 
 
There was also a significant increase in the mean CD8 +T 
cells in HIV seropositive subjects compared with the male 
controls. Table 3 shows the mean levels of fertility 
hormones, CD4 + T cells and CD8 +T cells in HIV 
seropositive female subjects and control females. There were 
no significant differences in the fertility hormones but there 
was a significant decrease of CD4+ T cells and a significant 
increase of CD8+ T cells levels of HIV seropositive female 
subjects compared with the control females. 
 
DISCUSSION 
It has been reported that infection by HIV/AIDS and the use 
of antiretroviral therapy are associated with a wide array of 
endocrine and metabolic abnormalities (Highleyman, 2010). 
There was a significant decrease in the mean serum levels of 
FSH, LH, prolactin and testosterone in HIV seropositive 
male subjects when compared with the HIV seronegative 
control subjects. This finding supports the report of 
Highleyman (2010). He stated that hypogonadism occurred 
in a majority of HIV seropositive men. The decrease may be 
as a result of disturbances in hypothalamic-pituitary-gonadal 
axis or due to metabolic abnormalities associated with 
HIV/AIDS. The low testosterone in HIV seropositive patients 
may results to a variety of symptoms including wasting, 
fatigue, anaemia, depression and loss of libido which is 
common to HIV seropositive patients (Highleyman, 2010) 
especially those with symptomatic HIV diseases.  
 Furthermore, no significant difference was found in the 
levels of fertility hormones in HIV seropositive females and 
HIV seronegative female control subjects. Although, 
previous studies on the impact of HIV on fertility hormones 
in women have been inconsistent, our findings are in support 
of those who suggested that HIV has little or no impact on 
menstrual function (Shah et al,1994; Ellerbrock et al,1996). 
They reported no significant differences in rates of 
amenorrhea, sparse or heavy menstruation or menstrual 
cramps between HIV seropositive and seronegative women. 
However, Ogundahunsi et al (2011) detected a significant 
decrease in the levels of fertility hormones in HIV women. 
They reported that treatment with ART improved lives, 
reduced the risk of opportunistic infections but do not have 
significant influence on the fertility hormones of HIV 
infected men and women.  
 This study also observed a significant decrease in 
CD4+T cells count and significant increase in the mean 
levels of CD8+ T cells count in HIV seropositive male and 
female subjects when compared with the HIV seronegative 
control subjects. This trend has been shown to be common to 
all HIV seropositive patients because CD4+Tcells are being 
attacked by the virus while CD8+Tcells are released to fight 
the virus (Oluboyo et al,2006; Schelleus et al., 2008). 
Although, Pohling et al (2010) stated that while antiretroviral 
suppression of HIV in chronic infection reduces HIV-specific 
CD8 +T cell response magnitude in the short term, it had no 
significant effect on response character over periods up to 9 
years. However, a recent finding has reported that a subset of 
CD4+ white blood cells invaded by HIV may control the 
course of the disease (Cohen, 2013). 
We conclude that HIV infection is associated with variations 
in the male hormonal fertility profiles but without significant 
effect on women hormonal fertility profiles. However, 
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